The role of long term acute care hospitals in prolonged mechanical ventilation
长期急症护理医院在延长机械通气方面的作用
基本信息
- 批准号:7904234
- 负责人:
- 金额:$ 6.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAdmission activityAgeAgingBedsCardiac Surgery proceduresCaringCase MixesCatastrophic IllnessChronicClinicalClinical effectivenessCohort StudiesCongestive Heart FailureCost SavingsCritical CareCritical IllnessDataDiagnosisEffectivenessEnd stage renal failureEvaluationGoalsHealth PolicyHealth systemHospital CostsHospitalsIncentivesIncidenceIntensive CareIntensive Care UnitsLength of StayLifeLong-Term CareLong-Term EffectsMalignant NeoplasmsMechanical ventilationMedicareMedicare claimMedicineModelingMyocardial InfarctionOrgan failureOutcomePatient CarePatient TransferPatientsPenetrationPoliciesPolicy MakerPopulationResource SharingResourcesRespiratory FailureRoleSelection BiasSeriesStatistical ModelsStrokeStructureSubgroupSurvivorsTestingTimeTraumaUnited StatesVariantWeaningbeneficiarycomparative effectivenesscosteconomic impactfinancial incentivehigh riskhospital patient careimprovedinsightinterestmortalitypublic health relevancetrend
项目摘要
DESCRIPTION (provided by applicant): Many patients with critical illness survive the acute episode yet have persistent organ failures requiring ongoing life support and the need for prolonged mechanical ventilation (PMV). PMV is an extraordinarily large financial and clinical burden on the health system-patients with PMV account for nearly half of all intensive care unit costs, and one-year mortality approaches 50%. Traditionally, patients requiring PMV have received their entire episode of acute care within a short stay hospital. However, in recent years there has been a dramatic increase in the use of long-term acute care (LTAC) hospitals for PMV. LTACs are the fastest growing segment of hospital medicine in the United States, increasing at a rate of 12% per year and accounting for $3.1 billion in Medicare spending during 2004 alone. Despite the rapid expansion of the LTAC model for patients with PMV, essential questions remain about their clinical effectiveness and impact on the cost of intensive care. LTACs could be cost-effective model of care for patients with PMV, could raise costs without impacting quality, or may even negatively impact outcomes compared to continued care in a short stay ICU. The overall objective of this application is to study the role of LTACs in the care of critically ill hospitalized patients. We will perform an observational cohort study using national claims data from Medicare beneficiaries and an instrumental variable approach to control for selection bias and unmeasured confounding. In Aim One we will examine the comparative effectiveness of LTACs for patients with PMV, looking at both survival and costs of care. In Aim Two we will determine if the clinical and economic impact of LTACs varies by either patient diagnosis or the type of LTAC--free standing versus vertically integrated (i.e. "hospitals-within-a-hospital"). In Aim Three we will evaluate the broader impact of LTAC penetration on acute care resource utilization and outcome, testing whether variation in LTAC availability and utilization is associated with resource utilization and outcomes for all hospitalized patients. This study will be the first rigorous analysis of LTAC utilization in critically ill patients and will provide key insight into the role of LTACs in the care of patients with respiratory failure and chronic critical illness. PUBLIC HEALTH RELEVANCE: Given the aging of the population and recent advances in critical care, the number of patients requiring PMV will rise in the coming years. Clinicians, policy makers and public have a strong interest in optimizing the structures of care for this high-risk, high-cost population. This project will directly inform key clinical and health policy decisions about long-term acute care hospitals and the care of patients with PMV.
描述(由申请人提供):许多重症患者在急性发作后幸存下来,但出现持续的器官衰竭,需要持续的生命支持并需要延长机械通气(PMV)。PMV对卫生系统来说是一个非常大的财务和临床负担,PMV患者占所有重症监护室费用的近一半,一年死亡率接近50%。传统上,需要PMV的患者在短期住院期间接受了整个急性护理。然而,近年来,PMV的长期急性护理(LTAC)医院的使用急剧增加。LTAC是美国医院医疗中增长最快的部分,每年以12%的速度增长,仅在2004年就占医疗保险支出的31亿美元。尽管PMV患者的LTAC模型迅速扩展,但关于其临床有效性和对重症监护费用的影响仍存在重要问题。LTAC可能是PMV患者的具有成本效益的护理模式,可能会在不影响质量的情况下增加成本,甚至可能会对短期ICU中的持续护理产生负面影响。本申请的总体目标是研究LTAC在重症住院患者护理中的作用。我们将使用来自医疗保险受益人的国家索赔数据和工具变量方法进行观察性队列研究,以控制选择偏倚和不可测量的混杂因素。在目标一中,我们将研究LTAC对PMV患者的比较有效性,观察生存率和护理费用。在目标二中,我们将确定LTAC的临床和经济影响是否因患者诊断或LTAC的类型而异-独立与垂直整合(即“医院中的医院”)。在目标三中,我们将评估LTAC渗透对急性护理资源利用和结局的更广泛影响,测试LTAC可用性和利用率的变化是否与所有住院患者的资源利用和结局相关。这项研究将是对危重患者LTAC利用率的首次严格分析,并将为LTAC在呼吸衰竭和慢性危重病患者护理中的作用提供关键见解。公共卫生相关性:鉴于人口老龄化和重症监护的最新进展,需要PMV的患者数量将在未来几年增加。临床医生、政策制定者和公众对优化这一高风险、高成本人群的护理结构有着浓厚的兴趣。该项目将直接为关于长期急性护理医院和PMV患者护理的关键临床和卫生政策决策提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeremy M Kahn其他文献
Leveraging Nurse-Patient Assignments to Improve Outcomes in Intensive Care.
利用护患分配来改善重症监护的结果。
- DOI:
10.4037/ccn2024380 - 发表时间:
2024 - 期刊:
- 影响因子:1.6
- 作者:
K. Riman;Jeremy M Kahn - 通讯作者:
Jeremy M Kahn
Jeremy M Kahn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeremy M Kahn', 18)}}的其他基金
Organizational strategies for improving evidence-uptake in intensive care
提高重症监护证据吸收的组织策略
- 批准号:
10065517 - 财政年份:2019
- 资助金额:
$ 6.9万 - 项目类别:
Organizational strategies for improving evidence-uptake in intensive care
提高重症监护证据吸收的组织策略
- 批准号:
10540743 - 财政年份:2019
- 资助金额:
$ 6.9万 - 项目类别:
Organizational strategies for improving evidence-uptake in intensive care
提高重症监护证据吸收的组织策略
- 批准号:
10307131 - 财政年份:2019
- 资助金额:
$ 6.9万 - 项目类别:
The effects of state sepsis mandates on hospital mortality, health care utilization, and costs
州脓毒症强制规定对医院死亡率、医疗保健利用率和成本的影响
- 批准号:
9980342 - 财政年份:2017
- 资助金额:
$ 6.9万 - 项目类别:
The effects of state sepsis mandates on hospital mortality, health care utilization, and costs
州脓毒症强制规定对医院死亡率、医疗保健利用率和成本的影响
- 批准号:
9554772 - 财政年份:2017
- 资助金额:
$ 6.9万 - 项目类别:
Novel approaches to profiling hospitals on critical illness mortality
分析医院危重病死亡率的新方法
- 批准号:
9231482 - 财政年份:2015
- 资助金额:
$ 6.9万 - 项目类别:
Novel approaches to profiling hospitals on critical illness mortality
分析医院危重病死亡率的新方法
- 批准号:
9031140 - 财政年份:2015
- 资助金额:
$ 6.9万 - 项目类别:
Organizational Determinants of ICU Telemedicine Effectiveness
ICU 远程医疗有效性的组织决定因素
- 批准号:
9061809 - 财政年份:2014
- 资助金额:
$ 6.9万 - 项目类别:
Organizational Determinants of ICU Telemedicine Effectiveness
ICU 远程医疗有效性的组织决定因素
- 批准号:
9277535 - 财政年份:2014
- 资助金额:
$ 6.9万 - 项目类别:
Organizational Determinants of ICU Telemedicine Effectiveness
ICU 远程医疗有效性的组织决定因素
- 批准号:
8753271 - 财政年份:2014
- 资助金额:
$ 6.9万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 6.9万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 6.9万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 6.9万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 6.9万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 6.9万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 6.9万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 6.9万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 6.9万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 6.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 6.9万 - 项目类别:
Operating Grants